124 related articles for article (PubMed ID: 18794193)
1. Radical chemoradiotherapy for adenocarcinoma of the distal oesophagus and oesophagogastric junction: what planning margins should we use?
Whitfield GA; Jackson A; Moore C; Price P
Br J Radiol; 2008 Dec; 81(972):921-34. PubMed ID: 18794193
[TBL] [Abstract][Full Text] [Related]
2. A prospective study to evaluate the impact of FDG-PET on CT-based radiotherapy treatment planning for oesophageal cancer.
Leong T; Everitt C; Yuen K; Condron S; Hui A; Ngan SY; Pitman A; Lau EW; MacManus M; Binns D; Ackerly T; Hicks RJ
Radiother Oncol; 2006 Mar; 78(3):254-61. PubMed ID: 16545881
[TBL] [Abstract][Full Text] [Related]
3. IMRT for prostate cancer: defining target volume based on correlated pathologic volume of disease.
Teh BS; Bastasch MD; Wheeler TM; Mai WY; Frolov A; Uhl BM; Lu HH; Carpenter LS; Chiu JK; McGary J; Woo SY; Grant WH; Butler EB
Int J Radiat Oncol Biol Phys; 2003 May; 56(1):184-91. PubMed ID: 12694837
[TBL] [Abstract][Full Text] [Related]
4. The value of magnetic resonance imaging in target volume delineation of base of tongue tumours--a study using flexible surface coils.
Ahmed M; Schmidt M; Sohaib A; Kong C; Burke K; Richardson C; Usher M; Brennan S; Riddell A; Davies M; Newbold K; Harrington KJ; Nutting CM
Radiother Oncol; 2010 Feb; 94(2):161-7. PubMed ID: 20096947
[TBL] [Abstract][Full Text] [Related]
5. DeepTarget: Gross tumor and clinical target volume segmentation in esophageal cancer radiotherapy.
Jin D; Guo D; Ho TY; Harrison AP; Xiao J; Tseng CK; Lu L
Med Image Anal; 2021 Feb; 68():101909. PubMed ID: 33341494
[TBL] [Abstract][Full Text] [Related]
6. Adenocarcinoma of the esophagogastric junction: the pattern of metastatic lymph node dissemination as a rationale for elective lymphatic target volume definition.
Meier I; Merkel S; Papadopoulos T; Sauer R; Hohenberger W; Brunner TB
Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1408-17. PubMed ID: 18374226
[TBL] [Abstract][Full Text] [Related]
7. Application of serial section method to determine the radiotherapy target volume for esophageal squamous carcinoma.
Song Y; Liang Y; Zang R; Hu L; Zhu S
Cell Biochem Biophys; 2013 Jun; 66(2):351-6. PubMed ID: 23325307
[TBL] [Abstract][Full Text] [Related]
8. Recommendations for the use of radiotherapy in nodal lymphoma.
Hoskin PJ; Díez P; Williams M; Lucraft H; Bayne M;
Clin Oncol (R Coll Radiol); 2013 Jan; 25(1):49-58. PubMed ID: 22889569
[TBL] [Abstract][Full Text] [Related]
9. [Choice of optimal margins in prostate conformal radiotherapy].
Khalifa J; Commandeur F; Bachaud JM; de Crevoisier R
Cancer Radiother; 2013 Oct; 17(5-6):461-9. PubMed ID: 23973458
[TBL] [Abstract][Full Text] [Related]
10. [Target volume margins for lung cancer: internal target volume/clinical target volume].
Jouin A; Pourel N
Cancer Radiother; 2013 Oct; 17(5-6):428-33. PubMed ID: 23988437
[TBL] [Abstract][Full Text] [Related]
11. Pathological analysis of clinical target volume margin for radiotherapy in patients with esophageal and gastroesophageal junction carcinoma.
Gao XS; Qiao X; Wu F; Cao L; Meng X; Dong Z; Wang X; Gao G; Wu TT; Komaki R; Chang JY
Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):389-96. PubMed ID: 17236963
[TBL] [Abstract][Full Text] [Related]
12. Adequate margins for random setup uncertainties in head-and-neck IMRT.
Astreinidou E; Bel A; Raaijmakers CP; Terhaard CH; Lagendijk JJ
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):938-44. PubMed ID: 15708278
[TBL] [Abstract][Full Text] [Related]
13. [Radiotherapy in cancers of the oesophagus, the gastric cardia and the stomach].
Créhange G; Huguet F; Quero L; N'Guyen TV; Mirabel X; Lacornerie T
Cancer Radiother; 2016 Sep; 20 Suppl():S161-8. PubMed ID: 27523409
[TBL] [Abstract][Full Text] [Related]
14. Geographic miss of lung tumours due to respiratory motion: a comparison of 3D vs 4D PET/CT defined target volumes.
Callahan J; Kron T; Siva S; Simoens N; Edgar A; Everitt S; Schneider ME; Hicks RJ
Radiat Oncol; 2014 Dec; 9():291. PubMed ID: 25511904
[TBL] [Abstract][Full Text] [Related]
15. The role of PET in target localization for radiotherapy treatment planning.
Rembielak A; Price P
Onkologie; 2008 Feb; 31(1-2):57-62. PubMed ID: 18268401
[TBL] [Abstract][Full Text] [Related]
16. The role of endoscopic ultrasound (EUS) in planning radiotherapy target volumes for oesophageal cancer.
Thomas E; Crellin A; Harris K; Swift S; Montefiore DS
Radiother Oncol; 2004 Nov; 73(2):149-51. PubMed ID: 15542161
[TBL] [Abstract][Full Text] [Related]
17. Physical considerations on discrepancies in target volume delineation.
Moeckli R; Sozzi WJ; Mirimanoff RO; Ozsahin M; Zouhair A; Valley JF; Bochud F
Z Med Phys; 2009; 19(4):224-35. PubMed ID: 19962081
[TBL] [Abstract][Full Text] [Related]
18. Variation in radiotherapy target volume definition, dose to organs at risk and clinical target volumes using anatomic (computed tomography) versus combined anatomic and molecular imaging (positron emission tomography/computed tomography): intensity-modulated radiotherapy delivered using a tomotherapy Hi Art machine: final results of the VortigERN study.
Chatterjee S; Frew J; Mott J; McCallum H; Stevenson P; Maxwell R; Wilsdon J; Kelly CG
Clin Oncol (R Coll Radiol); 2012 Dec; 24(10):e173-9. PubMed ID: 23079100
[TBL] [Abstract][Full Text] [Related]
19. Convolution method and CTV-to-PTV margins for finite fractions and small systematic errors.
Gordon JJ; Siebers JV
Phys Med Biol; 2007 Apr; 52(7):1967-90. PubMed ID: 17374922
[TBL] [Abstract][Full Text] [Related]
20. Comparison of margins, integral dose and interfraction target coverage with image-guided radiotherapy compared with non-image-guided radiotherapy for bladder cancer.
Foroudi F; Pham D; Bressel M; Hardcastle N; Gill S; Kron T
Clin Oncol (R Coll Radiol); 2014 Aug; 26(8):497-505. PubMed ID: 24726459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
